Featured Research

from universities, journals, and other organizations

First measurements of harmful haloacetic acids in urine of swimmers and pool workers

Date:
July 27, 2011
Source:
American Chemical Society
Summary:
The first scientific measurements in humans show that potentially harmful haloacetic acids (HAAs) appear in the urine of swimmers within 30 minutes after exposure to chlorinated water where HAAs form as a byproduct of that water disinfection method. The study found that HAAs also appeared in the urine of swimming pool workers.

The first scientific measurements in humans show that potentially harmful haloacetic acids (HAAs) appear in the urine of swimmers within 30 minutes after exposure to chlorinated water where HAAs form as a byproduct of that water disinfection method.
Credit: Photo Passion / Fotolia

The first scientific measurements in humans show that potentially harmful haloacetic acids (HAAs) appear in the urine of swimmers within 30 minutes after exposure to chlorinated water where HAAs form as a byproduct of that water disinfection method. Reported in the ACS journal Environmental Science & Technology, the study found that HAAs also appeared in the urine of swimming pool workers.

Mercedes Gallego and M.J. Cardador point out that government regulations in the United States and Europe limit the levels of HAAs that can appear in drinking water, also purified mainly by chlorination. The limits stem from research suggesting that elevated levels of HAAs in municipal drinking water supplies may be linked to birth defects and a higher incidence of some cancers. However, few studies have examined HAA exposure from swimming pools, where water may contain higher levels due to recirculation systems that lengthen water's exposure to chlorine and provide more time for HAAs to form.

Gallego and Cardador measured HAA levels in the urine of 49 volunteers who swam in or worked around an indoor and outdoor pool. "The results showed that HAAs appeared 20-30 minutes after exposure and were eliminated [from the body] within three hours," they note. Over 90 percent of the exposures probably occurred as a result of swallowing pool water. Far fewer HAAs were inhaled or taken in through the skin. Children were more likely than adults to have a high concentration of HAAs after swimming and swimmers accumulated HAAs almost four times as fast as people working around the pool.

The authors acknowledge funding from the Spanish Ministry of Science and Innovation, the Junta de Andalucia, and FEDER.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. J. Cardador, M. Gallego. Haloacetic Acids in Swimming Pools: Swimmer and Worker Exposure. Environmental Science & Technology, 2011; 45 (13): 5783 DOI: 10.1021/es103959d

Cite This Page:

American Chemical Society. "First measurements of harmful haloacetic acids in urine of swimmers and pool workers." ScienceDaily. ScienceDaily, 27 July 2011. <www.sciencedaily.com/releases/2011/07/110727121602.htm>.
American Chemical Society. (2011, July 27). First measurements of harmful haloacetic acids in urine of swimmers and pool workers. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/07/110727121602.htm
American Chemical Society. "First measurements of harmful haloacetic acids in urine of swimmers and pool workers." ScienceDaily. www.sciencedaily.com/releases/2011/07/110727121602.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins